A trial stimulation system includes a trial electrical stimulator. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

A method of evaluating an implantation of a lead is disclosed. Via a graphical user interface of an electronic device, a visual representation of a sacrum of the patient and a lead that is implanted in the sacrum is displayed. The lead includes a plurality of electrode contacts. An evaluation is made as to how well the lead has been implanted in the sacrum based on the visual representation of the sacrum and the lead. The evaluating comprises: determining whether the lead is inserted in a predetermined region of the sacrum, determining how far a predetermined one of the electrode contacts is located from an edge of the sacrum, and determining a degree of curvature of the lead.

A trial stimulation system includes a trial electrical stimulator. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Systems and methods for active charge-balancing for high frequency neural stimulation are disclosed. One illustrative method described herein includes: applying, through a pair of electrodes electrically coupled to a bundle of nerve fibers during a stimulation phase of a neural stimulation procedure, a first current to the bundle of nerve fibers; applying, through the pair of electrodes during a recovery phase of the neural stimulation procedure, a second current to the bundle of nerve fibers, the first current and the second current having opposite polarities; determining sampled voltages between the pair of electrodes during the stimulation phase, during the recovery phase, or between the stimulation phase and the recovery phase; determining a charge buildup in the bundle of nerve fibers based on the sampled voltages; applying, through the pair of electrodes during the stimulation phase or during the recovery phase, a delta current to the bundle of nerves based on the sampled voltages to minimize the charge build up.

Methods and systems for using evoked neural response to inform aspects of deep brain stimulation therapy are disclosed. According to some embodiments, a series of evoked neural response signals are recorded, and one or more waveform features are extracted from each of the signals. The waveform features can be used as biomarkers and or control signals for informing aspects of the therapy, such as lead implantation/localization, optimization of stimulation parameters, and/or closed loop feedback for maintaining chronic therapy. Embodiments include a check to determine and classify if any of the recorded neural response signals or portions thereof are corrupted. In the event that any of the signals are corrupted, values for the waveform features for the corrupted signals are interpolated using uncorrupted neural response signals in the series and/or uncorrupted portions of the problem neural response signal.

One or more antennas are electrically coupled to one or more switches of an implantable medical device (IMD) in which the one or more switches are additionally electrically coupled to one or more lead wires of an IMD lead. The one or more switches also are electrically coupled to one or more electrodes or electrical circuitry of the IMD's implantable pulse generator (IPG). In response to exposure of the IMD to an energetic electromagnetic field, a voltage signal is induced in the one or more antennas and provided, possibly via one more filters, as a control signal to the one or more switches. Receipt of the control signal by the one or more switches automatically configures the one or more switches into a non-conductive state, thereby electrically isolating the one or more lead wires from the one or more electrodes or the IPG electrical circuitry.

A wireless charger system for inductively charging a rechargeable battery of an implantable pulse generator (IPG) implanted in a human body is provided. A charging coil in the charger is wirelessly coupled to a receiving coil of the IPG to charge the rechargeable battery. An end-of-charge (EOC) circuit continuously monitors the reflected impedance from a reflected impedance sensor and determines the end of charge when a predetermined pattern of the reflected impedance corresponding to an EOC signal from the IPG is received. Advantageously, receiving the EOC signal through the charging coil eliminates the need to provide a separate communication circuit in the IPG that communicates with the charger.

In some examples, a method including detecting, via processing circuitry, an induced voltage in at least one of an electrode or a lead conductor of an implantable medical device, wherein the induced voltage is induced in the at least one of the electrode or the lead conductor of the implantable medical device by a radio frequency (RF) field generated by a magnetic resonance imaging (MRI) scanner; and modifying, via the processing circuitry, an MRI scan based on the detected induced voltage.

A method comprising detecting an epileptic event in a patient; applying an electrical therapy to a first target area in at least one of a brain region or a cranial nerve of said patient in response to said detecting; receiving a body signal responsive to the electrical therapy, wherein said body signal is selected from an autonomic signal, a neurologic signal, a metabolic signal, an endocrine signal, or a tissue stress marker signal; determining whether said body signal indicates that said electrical therapy has an efficacious effect; and terminating the application of said electrical therapy if the response indicates that the electrical therapy has an efficacious effect. An apparatus capable of performing the method. A non-transitive, computer-readable storage device for storing data that when executed by a processor, perform the method.

The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting the perception of pain while preserving other sensory and motor function, and proprioception.